Melanie Oates

Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

The unfolded protein response influences therapy outcome and disease progression in chronic lymphocytic leukaemia.

The unfolded protein response influences therapy outcome and disease progression in chronic lymphocytic leukaemia.

Journal: Scientific reports
Published: March 26, 2025

Re-emergence of circulating non-malignant B cells as a prognostic biomarker in chronic lymphocytic leukaemia.

Re-emergence of circulating non-malignant B cells as a prognostic biomarker in chronic lymphocytic leukaemia.

Journal: Scientific reports
Published: March 11, 2025

Influence of polyfunctional Tbet+ T cells on specific clinical events in chronic lymphocytic leukaemia.

Influence of polyfunctional Tbet+ T cells on specific clinical events in chronic lymphocytic leukaemia.

Journal: Frontiers in immunology
Published: November 14, 2024

Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.

Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.

Journal: British journal of haematology
Published: April 08, 2024

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features.

Journal: Nature genetics
Published: April 30, 2021

Development of a cell-line model to mimic the pro-survival effect of nurse-like cells in chronic lymphocytic leukemia.

Development of a cell-line model to mimic the pro-survival effect of nurse-like cells in chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma
Published: August 29, 2020

Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells.

Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells.

Journal: Scientific reports
Published: July 24, 2020

Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.

Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.

Journal: Haematologica
Published: February 13, 2020

An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects.

An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects.

Journal: BMC research notes
Published: April 02, 2018

Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia.

Delineating the distinct role of AKT in mediating cell survival and proliferation induced by CD154 and IL-4/IL-21 in chronic lymphocytic leukemia.

Journal: Oncotarget
Published: November 16, 2016

Correction: Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.

Correction: Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.

Journal: PloS one
Published: March 24, 2016

Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.

Evaluation of High-Throughput Genomic Assays for the Fc Gamma Receptor Locus.

Journal: PloS one
Published: June 16, 2015
Showing 1-12 of 20

Last Updated: 09/26/2026